Dimension Therapeutics Receives $65,000,000 Series B Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=e457fe9f-80f8-4ab4-833b-3247b45da384
Date
4/21/2015
Company Name
Dimension Therapeutics
Mailing Address
840 Memorial Drive 4th Floor Cambridge, MA 02139 USA
Company Description
Dimension Therapeutics is a gene therapy company focused on developing novel treatments for rare diseases. The company was launched in 2013 by Fidelity Biosciences and REGENX Biosciences. Dimension has now raised $30M with funding from Fidelity Biosciences and OrbiMed.
Website
http://www.dimensiontx.com
Transaction Type
Venture Equity
Transaction Amount
$65,000,000
Transaction Round
Series B
Proceeds Purposes
Dimension plans to use the proceeds from the financing to further advance the company’s adeno-associated virus (AAV) platform and growing pipeline of gene therapy programs.
M&A Terms
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor
Venture Investor